Repositioning Candidate Details

Candidate ID: R1281
Source ID: DB09282
Source Type: approved; investigational
Compound Type: small molecule
Compound Name: Molsidomine
Synonyms: Molsidomine
Molecular Formula: C9H14N4O4
SMILES: CCOC(=O)[N-]C1=C[N+](=NO1)N1CCOCC1
Structure:
DrugBank Description: Molsidomine is an orally active, long-acting vasodilator, which belongs to the class of medications known as syndnones. Interestingly, it is being studied as being a preventive measure in cerebral infarction .
CAS Number: 25717-80-0
Molecular Weight: 242.235
DrugBank Indication: The indications for use of molsidomine include ischemic heart disease, angina, chronic heart failure, and pulmonary hypertension .
DrugBank Pharmacology: Molsidomine leads to smooth muscle relaxation in the coronary blood vessels, relieving symptoms of angina and increasing blood flow to the coronary arteries.
DrugBank MoA: Molsidomine, a cardiovascular drug, acts in a similar fashion to organic nitrates. The SIN-1A metabolite of molsidomine has a pharmacologically active group of nitric oxide, which increases levels of cyclic GMP, and decreases intracellular calcium ions in smooth muscle cells. This leads to relaxation of smooth muscle in the blood vessels, and inhibits platelet aggregation.
Targets: Guanylate cyclase soluble subunit alpha-2 agonist
Inclusion Criteria: Therapeutic strategy associated